Venlafaxine Dosing: Starting and Maximum Doses
For adult patients with major depression, start venlafaxine immediate-release at 75 mg/day divided into 2-3 doses with food, with a maximum dose of 375 mg/day; for extended-release formulations, start at 75 mg once daily with a maximum of 225 mg/day. 1
Starting Dose
The FDA-approved starting dose is 75 mg/day for venlafaxine immediate-release tablets, administered in two or three divided doses with food 1. For the extended-release (XR) formulation, initiate at 75 mg once daily 2.
- This starting dose applies to standard adult outpatients with major depression
- Taking with food is important to optimize absorption and tolerability
- The immediate-release formulation requires divided dosing (BID or TID), while XR allows convenient once-daily administration
Maximum Dose
The maximum dose varies by formulation and clinical setting:
Outpatient setting:
- Standard maximum: 225 mg/day 1
- Absolute maximum: 375 mg/day for severely depressed patients who may require higher doses 1
Inpatient setting:
- More severely depressed inpatients responded to a mean dose of 350 mg/day 1
- Maximum studied: 375 mg/day in hospitalized patients with melancholic depression 1
Dose Titration Strategy
When increasing the dose:
- Use increments of up to 75 mg/day 1
- Wait at least 4 days between dose increases 1
- Titrate based on tolerability and clinical response
- Evidence shows a dose-response relationship in the 75-225 mg/day range 1, 3
Important caveat: While outpatient studies showed no evidence of additional benefit above 225 mg/day for moderately depressed patients, more severely depressed individuals (particularly inpatients) may respond better to higher doses up to 375 mg/day 1. This represents a critical clinical decision point—assess depression severity to determine if pushing beyond 225 mg/day is warranted.
Special Population Adjustments
Hepatic impairment:
- Reduce total daily dose by 50% in mild to moderate hepatic impairment 1
- May require >50% reduction in severe cirrhosis due to high individual variability 1
Renal impairment:
- Reduce total daily dose by 25% in mild to moderate renal impairment (GFR 10-70 mL/min) 1
- Reduce by 50% in patients on hemodialysis 1
Elderly patients:
- No specific dose adjustment required based on age alone 1
- However, use caution and consider starting at approximately 50% of the standard adult dose given increased risk of adverse reactions in older adults 4
- Exercise extra care when titrating upward 1
Clinical Pearls
The guideline reference 4 lists venlafaxine's dosage range as 37.5-225 mg/day for general outpatient use, which aligns with the FDA labeling for standard cases. However, the FDA label 1 clearly permits up to 375 mg/day for severe depression, particularly in inpatient settings.
Common pitfall: Stopping at 225 mg/day in a severely depressed patient who hasn't responded adequately. The evidence supports careful titration to 350-375 mg/day in treatment-resistant or severe cases 1, 5, though this requires close monitoring for adverse effects, particularly blood pressure elevation at higher doses 6.
Nausea is the most common adverse event, typically occurring in the first 2 weeks with low likelihood of developing thereafter 2. This is dose-dependent and more common with immediate-release formulations.